Cme (CME) EPS (Basic) (2009 - 2026)

Cme (CME) has reported EPS (Basic) for 18 consecutive years, with $2.89 the latest figure, recorded in Q2 2026.

• Quarterly EPS (Basic) rose 2.63% year-over-year to $2.89 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $11.85 (up 14.53% YoY) and the FY2025 annual result came in at $11.18, up 15.41% from the prior year.
• EPS (Basic) retreated to $2.89 in Q2 2026 per CME's latest filing, from $3.25 in the prior quarter.
• Over the last five years, EPS (Basic) for CME reached as high as $3.25 in Q1 2026 and fell as low as $1.76 in Q4 2022.
• A 5-year average of $2.41 and a median of $2.42 in 2024 frame the typical range for EPS (Basic).
• Annual changes were most pronounced in 2022 — EPS (Basic) retreated 27.64% — and 2025, when it jumped 35.13%.
• Year by year, EPS (Basic) stood at $1.76 in 2022, then rose by 27.56% to $2.24 in 2023, then increased by 7.28% to $2.4 in 2024, then jumped by 35.13% to $3.25 in 2025, then fell by 11.06% to $2.89 in 2026.
• According to Business Quant data, EPS (Basic) over the past three periods registered $2.89, $3.25, and $3.25 for Q2 2026, Q1 2026, and Q4 2025 respectively.